What is Regenxbio's deferred revenue?

Regenxbio (RGNX) reported deferred revenue of $5.92M in Q1 2026.

How has Regenxbio's deferred revenue changed year-over-year?

Regenxbio's deferred revenue decreased by 56.4% year-over-year, from $13.59M to $5.92M.

What is the long-term trend for Regenxbio's deferred revenue?

Over 5 years (2020 to 2025), Regenxbio's deferred revenue has grown at a 87.7% compound annual growth rate (CAGR), from $449K to $10.45M.

What does deferred revenue mean?

Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.

Regenxbio RGNX Deferred Revenue

Deferred Revenue at other companies

Regeneron PharmaceuticalsREGN

$636.2M+2.7%

Sarepta Therapeutics, Inc.SRPT

$116.04M+159%

EyePoint, Inc. EYPT

$0-100%

4D Molecular TherapeuticsFDMT

$360K-58.4%

PrecigenPGEN

$410K-25.3%

Viridian Therapeutics, Inc.VRDN

$274K-4.9%

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's deferred revenue?: Regenxbio (RGNX) reported deferred revenue of $5.92M in Q1 2026.
How has Regenxbio's deferred revenue changed year-over-year?: Regenxbio's deferred revenue decreased by 56.4% year-over-year, from $13.59M to $5.92M.
What is the long-term trend for Regenxbio's deferred revenue?: Over 5 years (2020 to 2025), Regenxbio's deferred revenue has grown at a 87.7% compound annual growth rate (CAGR), from $449K to $10.45M.
What does deferred revenue mean?: Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.